💊

Qtern

saxagliptin;dapagliflozin

Diabetes mellitus, typ 2;Diabetes mellitus;Närings- och metabola sjukdomar;Metabola sjukdomar;Glukosmetabolismstörningar

✅ Auktoriserad

✅

Inga aktiva aviseringar

Denna medicin har inga pågående brister, säkerhetsbrev eller återkallelser.

Vad det används till

Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus: to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control, when already being treated with the free combination of dapagliflozin and saxagliptin. (See sections 4.2, 4.4, 4.5 and 5.1 for available data on combinations studied.)

⚠️ Patientsäkerhet

Officiell EMA-sida

https://www.ema.europa.eu/en/medicines/human/EPAR/qtern